Sun Pharma Open to Large Acquisitions Post-Ranbaxy Deal

Mumbai: Sun Pharmaceutical Industries Ltd, India's largest drug maker by sales, said on Wednesday that its $3.2-billion (Rs 19,840 crore at 1 dollar = 62 rupees) acquisition of smaller rival Ranbaxy Laboratories Ltd will not restrict it from making further large acquisitions. The company will look to invest more than $300 million (Rs 1,860 crore) in research and development and is not considering any job cuts post the close of t...